APA (7th ed.) Citation

M, P., L, S., M, K., Y, S., D, B., M, I., . . . M, M. (2025). Post-transplant cyclophosphamide, abatacept, and vedolizumab to prevent GVHD after hematopoietic stem cells transplantation in children with acute leukemia: Results of a prospective trial. Bone marrow transplantation, 60(7), 1070. https://doi.org/10.1038/s41409-025-02566-6

Chicago Style (17th ed.) Citation

M, Perminova, et al. "Post-transplant Cyclophosphamide, Abatacept, and Vedolizumab to Prevent GVHD After Hematopoietic Stem Cells Transplantation in Children with Acute Leukemia: Results of a Prospective Trial." Bone Marrow Transplantation 60, no. 7 (2025): 1070. https://doi.org/10.1038/s41409-025-02566-6.

MLA (9th ed.) Citation

M, Perminova, et al. "Post-transplant Cyclophosphamide, Abatacept, and Vedolizumab to Prevent GVHD After Hematopoietic Stem Cells Transplantation in Children with Acute Leukemia: Results of a Prospective Trial." Bone Marrow Transplantation, vol. 60, no. 7, 2025, p. 1070, https://doi.org/10.1038/s41409-025-02566-6.